Udg Healthcare (UDHCF) Rating Lowered to Sell at ValuEngine

Udg Healthcare (OTCMKTS:UDHCF) was downgraded by ValuEngine from a “hold” rating to a “sell” rating in a note issued to investors on Tuesday, ValuEngine reports.

Other research analysts have also recently issued reports about the stock. Zacks Investment Research cut shares of Udg Healthcare from a “buy” rating to a “hold” rating in a research note on Thursday, March 14th. Barclays raised shares of Udg Healthcare from an “equal weight” rating to an “overweight” rating in a research note on Thursday, April 4th.

Shares of UDHCF traded up $0.25 during mid-day trading on Tuesday, hitting $8.35. 1,000 shares of the company’s stock were exchanged, compared to its average volume of 10,009. Udg Healthcare has a 52 week low of $7.25 and a 52 week high of $12.95.

About Udg Healthcare

UDG Healthcare plc, together with its subsidiaries, provides advisory, communication, commercial, clinical, and packaging services in the Republic of Ireland, the United Kingdom, North America, and internationally. The company operates in two segments, Ashfield and Sharp. The Ashfield segment offers commercialization services for the pharmaceutical and healthcare industry in the areas of advisory, communications, and commercial and clinical services.

Read More: Outstanding Shares, Buying and Selling Stocks

To view ValuEngine’s full report, visit ValuEngine’s official website.

Receive News & Ratings for Udg Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Udg Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.



Comments


share news on Facebook
tweet this investment news
share on linkedin
share on StockTwits
share on reddit